Delivery Order SPE2DB20D3103-SPE2DB26FL4N3
- Not listed
- The Defense Logistics Agency awarded a Delivery Order valued at $4,542.74 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count packages) with a completion date of October 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This is a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units). This contract, issued on March 18, 2025, with an ultimate completion date of April 8, 2025, operates under a firm fixed-price structure with no set-aside designation. The award represents a competitive procurement action, reflecting the vendor's established capability to meet federal pharmaceutical supply requirements....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a contract ceiling value of $4,542.74 and a firm fixed price structure. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by July 2, 2025. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $45,427.20 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120 count) with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for Yonsa 125 mg tablets (120-count supply) with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120 count) under a firm fixed-price contract type. The award, valued at $6.8K, was made on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a firm fixed price of $2,271.36 and an ultimate completion date of October 16, 2025. This is a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yonsa 125 mg tablets (120 count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a ceiling value of $4,542.74 and a completion date of October 14, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4N3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) valued at $4,542.72, with an ultimate completion date of November 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime vehicle valued through December 2026 that serves as a global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies the Defense Health Agency and other government healthcare systems with an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The firm's consistent receipt of competitively awarded federal contracts demonstrates its capability to meet stringent federal procurement requirements while supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 10/30/25 |